Moderna Q2 2025 slides: Revenue falls 41% as company pivots to diversified pipeline
NegativeFinancial Markets

Moderna reported a significant 41% drop in revenue for the second quarter of 2025, prompting the company to shift its focus towards a more diversified pipeline. This pivot is crucial as it reflects the challenges faced in the vaccine market and the need for innovation to sustain growth. Investors and stakeholders will be closely watching how this strategy unfolds, as it could determine the company's future in a competitive landscape.
— Curated by the World Pulse Now AI Editorial System









